Editorial statement — The case for a new journal in inflammation and pharmacology K. D. Rainsford EditorialNotes Pages: 1 - 2
Molecular pathology of drug-disease interactions in chronic autoimmune inflammatory diseases A. L. ParkeC. IoannidesD. V. Parke OriginalPaper Pages: 3 - 36
Relationship between enantiomer levels of flurbiprofen and clinical response in rheumatoid arthritis N. BellamyS. CoxJ. Campbell OriginalPaper Pages: 37 - 47
Solcoseryl prevents inflammatory and hypoxic but not toxic liver damage in rodents T. HartungM. LeistA. Wendel OriginalPaper Pages: 49 - 60
Conditional pharmacology: Expression of anti-inflammatory activity may require pre-existent inflammatory mediators and/or hormones M. W. WhitehouseB. Vernon-Roberts OriginalPaper Pages: 61 - 68
Pharmacokinetic interactions and adverse drug experiences in rheumatoid arthritis D. E. Furst OriginalPaper Pages: 69 - 77
Report on the 5th International Meeting of the Inflammation Research Association K. D. Rainsford Report Pages: 79 - 92